Queen City Angels

Queen City Angels (QCA) is an angel investment group based in Cincinnati, Ohio, established in 2000. The organization comprises experienced, accredited investors dedicated to fostering the growth of early-stage companies in Cincinnati and its surrounding areas. QCA focuses its investments on a diverse range of sectors, including advanced materials, life sciences, media, retail, electrical devices and supplies, financial services, and information technology. Through strategic investments, QCA aims to support entrepreneurs and drive substantial returns while contributing to the economic development of the region.

John Lilly

Investor Member

Past deals in Ohio

Kurome Therapeutics

Series A in 2021
Kurome Therapeutics, Inc. is a preclinical stage biotechnology company based in Cincinnati, Ohio, focused on developing innovative therapies for cancer treatment. Founded in 2019, the company specializes in targeting cancer cells that have hijacked immune signaling pathways to evade destruction by conventional therapies. By developing inhibitors that specifically address over-activated IRAK1/4-mediated signaling pathways, Kurome Therapeutics aims to disrupt the mechanisms that allow cancer cells to survive and resist treatment. Its approach is particularly relevant for hematological cancers, as it seeks to enhance the effectiveness of existing therapies and improve patient outcomes.

Standard Bariatrics

Series B in 2021
Standard Bariatrics is a medical device company based in Cincinnati, Ohio, specializing in the development of surgical instruments for weight-loss surgeries, particularly laparoscopic sleeve gastrectomy. Founded in 2014, the company has created a series of disposable surgical tools designed to work alongside general-use endoscopic staplers. These innovative tools help surgeons standardize their techniques, reduce variability, and minimize waste during procedures. By decreasing the number of cartridges needed for each surgery, Standard Bariatrics enables healthcare providers to lower costs while ensuring consistent surgical outcomes.

Airway Therapeutics

Series B in 2019
Airway Therapeutics, Inc. is a biopharmaceutical company focused on developing protein therapeutics for lung and pediatric applications. Founded in 2008 and headquartered in Cincinnati, Ohio, with an additional office in Marietta, Georgia, the company is engaged in licensing technology from the pulmonary research program of Cincinnati Children's Hospital Medical Center to enhance its development platform. Airway Therapeutics' key products include recombinant human surfactant protein-D, aimed at preventing bronchopulmonary dysplasia in premature infants, and AT100, a protein replacement therapy for the same condition. The company is dedicated to addressing various market needs related to respiratory and inflammatory diseases by creating innovative biologics that reduce inflammation, lower infection risks, and modulate the immune response, ultimately improving treatment outcomes for patients.

Standard Bariatrics

Series A in 2018
Standard Bariatrics is a medical device company based in Cincinnati, Ohio, specializing in the development of surgical instruments for weight-loss surgeries, particularly laparoscopic sleeve gastrectomy. Founded in 2014, the company has created a series of disposable surgical tools designed to work alongside general-use endoscopic staplers. These innovative tools help surgeons standardize their techniques, reduce variability, and minimize waste during procedures. By decreasing the number of cartridges needed for each surgery, Standard Bariatrics enables healthcare providers to lower costs while ensuring consistent surgical outcomes.

Airway Therapeutics

Series B in 2018
Airway Therapeutics, Inc. is a biopharmaceutical company focused on developing protein therapeutics for lung and pediatric applications. Founded in 2008 and headquartered in Cincinnati, Ohio, with an additional office in Marietta, Georgia, the company is engaged in licensing technology from the pulmonary research program of Cincinnati Children's Hospital Medical Center to enhance its development platform. Airway Therapeutics' key products include recombinant human surfactant protein-D, aimed at preventing bronchopulmonary dysplasia in premature infants, and AT100, a protein replacement therapy for the same condition. The company is dedicated to addressing various market needs related to respiratory and inflammatory diseases by creating innovative biologics that reduce inflammation, lower infection risks, and modulate the immune response, ultimately improving treatment outcomes for patients.

Supply Dynamics

Series A in 2017
Supply Dynamics, Inc. is a company that specializes in a cloud-based supply chain management platform designed to enhance visibility and control over materials and raw inventory. Founded in 2003 and headquartered in Loveland, Ohio, Supply Dynamics offers solutions that facilitate demand aggregation, sourcing, procurement, and supply monitoring across various industries, including aerospace and defense, automotive, electronics, and energy. Its platform enables manufacturers to reconnect finished goods demand with the underlying materials and processes used in production, helping them recover value throughout the raw material supply chain. By providing a non-invasive, multi-enterprise analytics suite, the company allows customers to collaborate with suppliers and manage parts sourcing decisions effectively, thus mitigating price volatility and improving overall efficiency. Additionally, Supply Dynamics employs a proprietary data conversion process and a unique metals price benchmarking solution to deliver comprehensive insights into material and process demand across the extended supply chain.

3Bar Biologics

Series A in 2017
3Bar Biologics Inc. is a bioscience company based in Columbus, Ohio, focused on enhancing agricultural productivity through innovative, sustainable solutions. Established in 2013, the company specializes in the development of Bio-YIELD, a microbe inoculant system that utilizes naturally occurring microbes tailored to specific crops and soil conditions. This all-natural product aims to increase crop yields while minimizing reliance on synthetic chemicals. Bio-YIELD was introduced to the market in 2014, initially targeting growers in the eastern Corn Belt, with plans for expansion as additional supporting data is generated. The formulation of Bio-YIELD is grounded in over 15 years of research conducted by scientists at The Ohio State University, who identified beneficial bacteria that contribute to healthier crops, including corn, soybean, and wheat. By aligning microbial solutions with agricultural practices, 3Bar Biologics seeks to provide farmers with ecologically sound products that protect their investments in land and seed.

Airway Therapeutics

Convertible Note in 2017
Airway Therapeutics, Inc. is a biopharmaceutical company focused on developing protein therapeutics for lung and pediatric applications. Founded in 2008 and headquartered in Cincinnati, Ohio, with an additional office in Marietta, Georgia, the company is engaged in licensing technology from the pulmonary research program of Cincinnati Children's Hospital Medical Center to enhance its development platform. Airway Therapeutics' key products include recombinant human surfactant protein-D, aimed at preventing bronchopulmonary dysplasia in premature infants, and AT100, a protein replacement therapy for the same condition. The company is dedicated to addressing various market needs related to respiratory and inflammatory diseases by creating innovative biologics that reduce inflammation, lower infection risks, and modulate the immune response, ultimately improving treatment outcomes for patients.

Healthy Roster

Seed Round in 2016
Founded in 2015, Healthy Roster develops a virtual athletic training app that tracks injuries, engages parents, and facilitates communication among trainers, coaches, administrators, and families. Its mobile sports-specific EHR enables high schools, middle schools, and youth leagues to provide instant access to certified athletic trainers and an injury communication platform.

NaviStone

Seed Round in 2016
NaviStone is a technology company based in Cincinnati, Ohio, specializing in website visitor and behavior tracking to enhance direct marketing efforts. Its primary product, NaviStone Prospecting, enables marketers to convert previously anonymous website visitors into identifiable postal addresses, facilitating targeted direct mail campaigns. By analyzing online browsing activity to gauge purchase intent, NaviStone helps businesses identify potential customers and supports various marketing strategies, including customer reactivation and abandoned cart email initiatives. The company serves a diverse range of industries, including nonprofit, consumer goods, publishing, retail, and financial services. NaviStone's innovative approach to leveraging first-party audience data enhances marketing efficiency and drives customer acquisition, positioning it as a leader in the field of offline retargeting technology.

Standard Bariatrics

Seed Round in 2016
Standard Bariatrics is a medical device company based in Cincinnati, Ohio, specializing in the development of surgical instruments for weight-loss surgeries, particularly laparoscopic sleeve gastrectomy. Founded in 2014, the company has created a series of disposable surgical tools designed to work alongside general-use endoscopic staplers. These innovative tools help surgeons standardize their techniques, reduce variability, and minimize waste during procedures. By decreasing the number of cartridges needed for each surgery, Standard Bariatrics enables healthcare providers to lower costs while ensuring consistent surgical outcomes.

MedaCheck

Series A in 2015
MedaCheck is a provider of a medication reminder system that combines hardware and software to educate, manage, and remind patients about their prescriptions and treatments. Its solution includes a hardware device known as a Pillbox and a software suite with CheckBox and CheckIn, which together notify patients of medication timings and facilitate communication with caregivers and healthcare professionals. The system supports real-time updates and coordinated care among patients, care teams, family members, and providers, helping clinicians and caregivers monitor patient health and adherence. It is designed for use by medical practices, telemedicine providers, health insurers, patient-centered medical homes, accountable care organizations, assisted living facilities, and pharmaceutical clients in the United States. Founded in 2012 and headquartered in Cincinnati, Ohio, MedaCheck aims to improve adherence and health outcomes through reminders, alerts, and ongoing patient education.

Airway Therapeutics

Series A in 2014
Airway Therapeutics, Inc. is a biopharmaceutical company focused on developing protein therapeutics for lung and pediatric applications. Founded in 2008 and headquartered in Cincinnati, Ohio, with an additional office in Marietta, Georgia, the company is engaged in licensing technology from the pulmonary research program of Cincinnati Children's Hospital Medical Center to enhance its development platform. Airway Therapeutics' key products include recombinant human surfactant protein-D, aimed at preventing bronchopulmonary dysplasia in premature infants, and AT100, a protein replacement therapy for the same condition. The company is dedicated to addressing various market needs related to respiratory and inflammatory diseases by creating innovative biologics that reduce inflammation, lower infection risks, and modulate the immune response, ultimately improving treatment outcomes for patients.

PlusBlue Solutions

Seed Round in 2014
PlusBlue Solutions, based in Cincinnati, Ohio, specializes in short-term rentals of high-quality portable battery packs designed for busy venues. The company provides customized chargers that are premium-grade and portable, compatible with any USB device, including phones and tablets. By offering these rental services, PlusBlue Solutions ensures that users can stay mobile and connected without the inconvenience of dead batteries, enhancing their experience in various public settings.

nChannel

Series A in 2013
nChannel, Inc. is a provider of cloud-based multichannel management software designed to facilitate efficient operations for merchants. Founded in 2011 and headquartered in Columbus, Ohio, the company offers a comprehensive platform that allows sellers to manage product information, synchronize inventory, and streamline order management across various sales channels, including e-commerce websites and brick-and-mortar stores. Its services include product information management, inventory synchronization, supply chain integration, and customer experience management, catering to a diverse range of industries such as outdoor goods, consumer products, and apparel. nChannel's subscription model enables businesses of all sizes to integrate their existing systems, such as ERP and POS, with external sales channels, enhancing operational efficiency and data visibility. The platform focuses on maximizing the utilization of existing systems, thereby improving the overall sales process for both wholesale and consumer markets.

Ischemia Care

Venture Round in 2013
Ischemia Care, LLC is a molecular diagnostic company based in Oxford, Ohio, that specializes in blood tests aimed at diagnosing the causes of ischemic strokes and transient ischemic attacks. Founded in 2002 and known previously as Gerard Ventures, LLC, the company offers various diagnostic tools, including the ISCDx test for stroke diagnosis based on gene expression analysis, which is critical for stratifying patients and guiding appropriate treatment. Additionally, it provides the ER Stroke Triage Test for quick confirmation of stroke in emergency settings and conducts laboratory testing under CLIA regulations. By utilizing blood testing as a clinical workflow tool, Ischemia Care enhances patient outcomes and aims to reduce hospital costs, empowering clinicians with vital information to prevent stroke recurrence and ensure timely interventions.

Neuros Medical

Series B in 2012
Neuros Medical, Inc. is a neuromodulation company dedicated to developing innovative therapies to address unmet medical needs for patients globally. Founded in 2008 and headquartered in Willoughby Hills, Ohio, the company specializes in its proprietary platform technology known as Electrical Nerve Block. This technology is designed to eliminate chronic pain across various conditions, including neuroma/residual limb pain, chronic post-surgical pain, and chronic migraine. The Neuros Altius System, one of its key products, includes an implantable generator with an integrated rechargeable battery, a cuff electrode, and external devices, further demonstrating the company's commitment to advancing pain management solutions.

Define My Style

Seed Round in 2011
Define My Style, Inc. is an online platform based in Cincinnati, Ohio, that fosters creativity and collaboration among aspiring designers and fashion enthusiasts. Established in 2011, the company allows members to engage in social commerce by choosing roles such as buyer, designer, marketer, critic, or influencer. It specializes in designing and selling custom handbags, offering a variety of products including mini, tote, messenger, overnight, and shopping bags, as well as assorted accessories. With a community of over 50,000 young women and a strong network of industry partners, Define My Style provides the tools and connections necessary for members to share ideas, participate in contests, and bring their fashion concepts to fruition.

Ischemia Care

Series B in 2011
Ischemia Care, LLC is a molecular diagnostic company based in Oxford, Ohio, that specializes in blood tests aimed at diagnosing the causes of ischemic strokes and transient ischemic attacks. Founded in 2002 and known previously as Gerard Ventures, LLC, the company offers various diagnostic tools, including the ISCDx test for stroke diagnosis based on gene expression analysis, which is critical for stratifying patients and guiding appropriate treatment. Additionally, it provides the ER Stroke Triage Test for quick confirmation of stroke in emergency settings and conducts laboratory testing under CLIA regulations. By utilizing blood testing as a clinical workflow tool, Ischemia Care enhances patient outcomes and aims to reduce hospital costs, empowering clinicians with vital information to prevent stroke recurrence and ensure timely interventions.

EndoSphere

Series A in 2011
Endosphere is a medical device company based in Columbus, Ohio, founded in 2006. It specializes in developing innovative non-invasive endoscopic therapies aimed at addressing gastrointestinal disorders and metabolic diseases, including obesity, non-alcoholic fatty liver disease, and type 2 diabetes. The company’s unique devices leverage the body’s natural physiology to facilitate safe and effective weight loss, eliminating the necessity for surgical interventions or medications. By focusing on non-invasive solutions, Endosphere aims to improve patient outcomes and enhance the treatment landscape for those suffering from these conditions.

Transactiv

Series A in 2009
Transactiv Inc., headquartered in Cincinnati with additional offices in Boulder, delivers on-demand commerce solutions tailored for mid-market companies. Its primary offerings are PartnerFront and StoreFront platforms, facilitating interactions between businesses and their partners, suppliers, affiliates, and customers. The company aims to connect millions of products and businesses effectively online, addressing a fundamental need in e-commerce.

AssureCare

Series C in 2007
AssureCare, LLC is a healthcare technology company based in Cincinnati, Ohio, specializing in integrated population care management software for healthcare and human services organizations. Founded in 1979 and previously known as CH Mack, Inc., AssureCare offers its flagship product, MedCompass, a comprehensive health management solution. MedCompass enables healthcare providers to efficiently manage utilization, case, and disease management, serving millions of patients across the United States. The software enhances care management by automating processes and streamlining workflows, which supports care professionals in making informed decisions that significantly improve the quality of care delivered. AssureCare's innovative approach connects healthcare providers and payers, fostering collaborative and cost-effective care through a fully integrated database of member and provider information.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.